Regulatory News In Brief
This article was originally published in The Tan Sheet
Executive Summary
FDA denies PSE market removal petition; Alabama drug offender registry bolsters NPLEx; FDA issues advisories on three products spiked with ED ingredient; advocacy group joins homeopathic lawsuit in Canada against Boiron.